Background and Objectives: Early microbial colonization has a key impact on infant health through nutritional, immunological, and metabolic programming. The origin of child snoring is multifactorial and complex, and may thereby also generate long-term health problems. The link between child snoring and gut microbes remains unclear, although indirect evidence exists regarding this relationship. This study aimed to characterize the connection between gut microbiota and child snoring. Methods: In a prospective, observational CHILD-SLEEP birth cohort study, gut microbiota in a subcohort of 43 of these children at 2 years of life was profiled with 16S ribosomal RNA gene amplicon sequencing. Results: A higher abundance of the Proteobacteria phylum, the Enterobacteriaceae family, and Erysipelotrichaceae family, as well as a higher ratio of Firmicutes to Bacteroidetes were detected in snorers as compared to controls. Furthermore, snorers showed significantly lower microbial diversity and richness than non-snorers. Conclusions: The snoring children manifest different gut microbiota as compared with healthy children. Considering that snoring and sleep disorders can be a source of long-term consequences, including cardiovascular, metabolic, immunological, neurocognitive and behavioral consequences, our results proposes early microbiota as a new treatment target.
T he sleeping patterns of healthy infants vary, but sleep-disordered breathing, affecting 1 infant in 10 (1-8) is not harmless. This disorder encompasses a group of conditions that range in severity and prognosis, with snoring being the most common symptom. Despite extensive research into the origins of infant snoring, the pathomechanisms involved remain unclear (9) .
Regardless of the potential causes, a child's snoring can be a source of long-term consequences, such as cardiovascular, metabolic, immunological, neurocognitive, and behavioral outcomes. Reversing this process requires identifying and characterizing the related mechanisms (10, 11) .
Snoring in otherwise healthy children coincides with several maturational processes that take place in the gastrointestinal tract, the largest portal for early environmental exposures, particularly microbial colonization, and food intake. Indeed, breast-feeding has been suggested as a potential protective element against childhood snoring (12, 13) . Interestingly, breast-feeding holds a key position with regard to promoting healthy, age-appropriate gut colonization (14) . In point of fact, early exposures that interfere with the compositional development of the intestinal microbiota have been associated with the development of diseases such as obesity, diabetes, allergies, and even neurodevelopmental disorders (15, 16) , which are also common consequences of child snoring. To uncover the impact of the earliest and the most massive environmental exposure, the present study was undertaken to characterize the interconnection between the gut microbiota and child snoring.
METHODS

Study Design
The original sample was composed of 1673 neonates and their parents from the CHILD-SLEEP birth cohort. The children were born between April 2011 and February 2013. The details of the
What Is Known
Child snoring is a multifactorial disorder that may have other health connections such as cardiovascular, metabolic, immunological, neurocognitive, and behavioral outcomes. Early microbiota has been related to risk of disease although the link between snoring and gut microbes remains to be uncovered.
What Is New
Snoring children harbors different microbiota when compared with healthy children presenting lower microbial diversity and higher abundance of proinflammatory bacteria and higher ratio of Firmicutes to Bacteroidetes. Our result suggest the impact of early microbiota as a new treatment target.
protocol and recruitment procedure have been reported previously (17) . The recruitment and baseline measurement occurred prenatally, and the follow-up evaluation included the birth characteristics and assessments at 3 months, 8 months, and 2 years of age, when questionnaires were provided to both the mothers and fathers.
The present study involves families who responded to the 8-and 24-month questionnaires concerning the child. The questionnaire was sent only to Finnish speakers. Thus, the majority of the families were Finnish. The CHILD-SLEEP study protocol was approved by the Ethics Committee of Pirkanmaa Hospital District (March 9, 2011, ethical research permission code R11032).
Study Subjects and Sampling
Families reporting snoring in their children were contacted by phone. Snoring frequency was confirmed in a brief interview. The inclusion criterion was that the child was snoring 3 or more times per week. Children who snored less than 3 times per week were defined as controls. At 8 months, 22 snorers and 13 nonsnorers (controls) were enrolled with parental consent, and these participants were re-evaluated at 24 months of age. Then, based on the questionnaire filled out at 24 months of age, new snorers were identified and recruited. Altogether, 32 snoring children and 20 controls completed the study protocol at 24 months. The protocol included an accurate physical examination by a pediatrician, together with anthropometric measurements. Fecal samples, collected at 24 months of age, were available from 27 snorers and 16 non-snorers, who comprised the final study population. Samples were frozen and stored at À808C for later analysis.
DNA Extraction and 16S gene Amplicon Sequencing
Total DNA was isolated from the fecal pellets as previously described (18) . Briefly, 100 to 125 mg of feces was weighed and homogenized in the presence of lysis buffer via bead-beating with FastPrep-24 (MP Biomedicals, Irvine, CA). DNA was extracted following the commercial kit InviMag Stool DNA kit (Stratec Molecular, Berlin, Germany) by use the automated KingFisher DNA system (Thermo Fisher Scientific Oy, Vantaa, Finland). The KingFisher's system protocol steps included nucleic acid binding on magnetic beads, 5-step washing, and elution.
Isolated DNA concentrations were measured using a Qubit 2.0 Fluorometer (Life Technology, Carlsbad, CA). The 16S rRNA gene (V3-V4 region) was amplified following Illumina protocols, and the libraries were sequenced using a 2 Â 300 pb paired-end run (MiSeq Reagent kit v3) on a MiSeq-Illumina platform (FISABIO Sequencing Service, Valencia, Spain) according to the manufacturer's instructions. To rule out and control for potential reagent contamination, the reagents for DNA extraction and PCR amplification were also sequenced as controls.
Bioinformatics and Statistical Analysis
Data processing was performed using the QIIME pipeline (Version 1.9.0, default parameters) (19) . Chimeric sequences and sequences that could not be aligned were removed from the dataset. An open reference Operational Taxonomic Unit (OTU) picking method with 97% identity to the Greengenes 13.8 database was selected. OTUs with a relative frequency below 0.01 and those that could not be classified at the domain level were removed from each sample. Sequences classified as cyanobacteria and chloroplasts were also removed from the dataset because they likely represent ingested plant material. Alpha diversity indices (Chao1 and Shannon), beta diversity based on unweighted UNIFRAC (phylogenetic) and Bray Curtis distance (non-phylogenetic) among the samples were obtained. PERMANOVA test was used to test for significance between groups. The analysis of composition of microbiomes (ANCOM) test for comparing the taxa abundance was obtained (20) . The DESeq2 method was also used to determine whether snoring status was associated with altered taxa abundance at the family, genus, and OTU levels. P values after false discovery rate (FDR) correction 0.05 were regarded as statistically significant. Calypso software Version 8.24 (http://cgenome.net/calypso/) was used, along with total sum normalization (TSS), for the statistical analysis and data mining. The bacterial profiles were further compared between snorers and controls via linear discriminant analysis (LDA), as well as effective size (LEfSe) pairwise analysis in a Galaxy environment using an alpha cutoff of 0.05 and an effect size cutoff of 2.0 (21). In order to assess the associations between microbiota and clinical variables (such as weight, BMI, and others). Spearman rank test correlations were calculated.
RESULTS
Gut Microbiota Composition in Snorers and Non-Snorers
In the study population (n ¼ 52), a total of 43 children with available fecal samples were included (n ¼ 27 snorers and n ¼ 16 controls). There were no significant differences in the clinical characteristics between the groups as shown in Table 1 . Significant differences in the gut microbiota between snorers and controls were found, as shown in the multivariate-method PERMANOVA with 999 permutations of the UNIFRAC distance (R 2 ¼ 0.0316, P ¼ 0.038 for unweighted UNIFRAC distance) and Bray-Curtis distance (non-phylogenetic distance, R 2 ¼ 0.0420, P ¼ 0.037). Furthermore, multivariate redundant discriminant analysis showed statistically significant differences in microbial composition between snorers and controls (variance ¼ 12.2, F model ¼ 1.30, P ¼ 0.048) (Fig. 1A and B) . Snorers showed lower microbial diversity (P ¼ 0.019, Shannon index) and richness (P ¼ 0.00634, Chao1 index) than non-snorers ( Fig. 1C and D) .
Specifically, the distinction was due to a higher abundance of members of the Proteobacteria phylum in snorers as compared to controls (1.06% vs 0.38%, P ¼ 0.01, FDR ¼ 0.06) (Fig. 2A) . A significantly higher ratio of Firmicutes to Bacteroidetes (P ¼ 0.036) and a lower ratio of Actinobacteria to Proteobacteria (P ¼ 0.006) was detected in snorers than in controls (Fig. 2C and D) . ANCOM test identified significant higher presence of Enterobacteriaceae family and at genus level, higher unclassified Enterobacteriaceae and Eubacterium in snorers as compared to controls. DESeq2 test was also used to identify the differential abundances of specific bacteria, snoring children showed significantly higher abundances of Enterobacteriaceae (P < 0.0001, FDR ¼ 0.0013) and Erysipelotrichaceae (P < 0.0001, FDR ¼ 0.0088), compared to controls.
LEfSe analysis shows a statistically significant enrichment of the Enterobacteriaceae and Erysipelotrichaceae families in snorers as compared to non-snorers (LDA score >3.90), while the unclassified Clostridiales and Ruminococcaceae families were enriched in controls (Fig. 3) . At the OTU level, the LefSe test showed the higher enrichment of specific OTUs, especially in those belonging to Bacteroidetes phylum, in snorers as compared to controls.
DISCUSSION
The redundancy of the Proteobacteria phylum in snorers, documented for the first time here, suggests a proinflammatory tone in the gastrointestinal microenvironment. The shift in bacterial profile culminates in a reduced Actinobacteria to Proteobacteria ratio in snorers as compared to children who are free of sleepdisordered breathing symptoms. Concomitantly, an increased ratio of Firmicutes to Bacteroidetes was documented in snorers. Analogous dysbiosis has previously been reported in obesity (22, 23) , with a heightened risk of cardiovascular, metabolic, and immunological disadvantages at later ages (23, 24) . Snoring has been reported to have identical long-term consequences (10, (25) (26) (27) (28) . Interestingly, in the present study, a snoring-associated shift in microbiota was observed in metabolically healthy, non-obese children. Taken previous demonstrations on the interlink between microbiota and human health together (29, 30) , we hypothesize here that aberrant gut microbiota, as a common denominator, might initiates immune and metabolic disturbances locally and, consequent to impaired gut barrier function, systemic chronic inflammation, might increase the risk of non-communicable diseases, such as allergy and asthma, as well as overweight and cardiovascular and neuropsychiatric disorders. Furthermore, snoring would also affect the physiological and behavioral outcomes affecting gut microbiota. Associations cannot be linked to causation and it is needed studies focused on the validation of causation and also, to identify other factors involved in the development of snoring problem and short-and long-term health outcomes.
Specifically, the distinctive microbiota profile of snorers showed consistently higher Enterobacteriaceae and Erysipelotrichaceae at both the phylum level and the genus level, and these findings were confirmed via the LEfSe analysis. The Enterobacteriaceae are a large family of gram-negative bacteria that along with many harmless symbionts, also harbors many common pathogens (eg, Salmonella, Escherichia coli). This family is the only representative of the Enterobacteriales order in the Gammaproteobacteria class and the Proteobacteria phylum, which is often associated with inflammation. The Erysipelotrichia are a class of bacteria in the Firmicutes phylum. Species of this class are known to predominate among the gut microbiome. Their predominance has been reported in diet-induced obesity (31) and in pediatric inflammatory bowel disease (32) .
Our results are in agreement with previous data on subjects suffering from partial sleep deprivation (33) . The study in question reported higher abundances of Coriobacteriaceae and Erysipelotrichaceae and lower abundance of Tenericutes (33) . Interestingly, the risk of insulin resistance, type 2 diabetes and obesity-metabolic pathologies that have been linked to deviant gut microbiotahave also been reported to result from chronic sleep deprivation (34) . It has been reported that frequent snoring in an adult population (35) is associated with higher levels of insulin, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), triglycerides, leptin, and inflammatory markers (such as C-reactive protein, interleukin-6 and -18 and lipopolysaccharide binding protein) and lower concentrations of high-density lipoprotein and adiponectin (35) . In agreement with these results, it has been reported that chronic sleep disruption in mice alters the gut microbiota and induces systemic and adipose tissue inflammation and insulin resistance (36) . Lipopolysaccharide binding protein has been suggested to be a marker of underlying low-grade endotoxemia in the gut. Lipopolysaccharide (LPS)-induced metabolic endotoxemia is the first step in the development of insulin resistance and diabetes (37, 38) . Gram-negative bacteria contain LPS as the major constituent of the outer leaflet of the outer cell membrane. Thus, the increased presence of gram-negative bacteria Proteobacteria would be related to increased LPS levels and inflammation. Dietary fats have been associated with the increased absorption of LPS, which in turn, may be related with specific gut microbiota changes, such as a FIGURE 2. Gut microbial profile in snorers and control infants. Relative abundances (%) at the phylum (A) and family levels (B) and, the ratios of Firmicutes to Bacteroidetes (C) and Actinobacteria to Proteobacteria (D) in each group. reduction in the Eubacterium rectale-Blautia coccoides group, Bacteroides, and Bifidobacterium (39). These results are in agreement with our findings regarding snorers as compared to controls. In support of our theory of dysbiosis as a causative mechanism in snoring and its debilitating consequences, children with obstructive sleep apnea have been shown to exhibit significantly higher LPSbinding protein in their plasma as compared with controls (28) .
More recently, obstructive sleep apnea (40) and sleep deprivation (41) have been characterized as a necessary initial step in oxidative stress and ATP depletion, or vice versa (42, 43) . The activation of the oxidative pathways in gut cells can be initiated by circulating inflammatory mediators or reactive oxygen or nitrogen species (42, 43) , which in the neonatal gut, are correlated with an abundance of the Enterobacteriaceae family (the Escherichia and Enterobacter genera) and a reduction of the Actinobacteria phylum (mainly Bifidobacterium genus) and Bacteroidetes (mainly Bacteroides genus) (44) .
Recent advances in microbiome research have inextricably linked gut bacteria to the development and function of the immune system, the metabolism and diseases as phenotypically different as inflammatory bowel disease, obesity, allergic diseases, and neurodevelopmental disorders. The present findings extend this list of conditions to include sleep-disordered breathing. Moreover, our data may furnish 1 explanation for the heightened risk of metabolic, immunological, neurocognitive, and behavioral consequences associated with snoring in infancy, with the common denominator being the aberrant compositional development of gut microbiota, or dysbiosis.
Snoring children manifest deviated microbiota as compared with healthy children. This result, if verified in other populations, invites the modification of the gut microbiota, or bringing the gut microbiota back into balance, as a new treatment target in children with sleep-disordered breathing.
